About Tapemark
Tapemark is a company based in Saint Paul (United States) founded in 1952 was acquired by LTS Lohmann in August 2022. Tapemark operates in a competitive market with competitors including Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
- Headquarter Saint Paul, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
LTS Lohmann
(Aug 19, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Tapemark
Unlock access to complete
Unlock access to complete
Funding Insights of Tapemark
Detailed funding history for Tapemark
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Tapemark
Tapemark has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include LTS Lohmann.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug delivery systems targeting multiple disease indications are developed.
|
Locked | Locked | Locked |
Investor details for Tapemark
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Tapemark
Investment portfolio details for Tapemark
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Tapemark
Detailed financials for Tapemark
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Tapemark Comparisons
Peer comparison for Tapemark
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Tapemark
Tapemark operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akums, Jubilant Life Sciences, Unither, Recipharm and Nectar Lifesciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
Detailed competitors of Tapemark
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Tapemark
Complete news archive for Tapemark
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tapemark
Tapemark was founded in 1952.
Tapemark is headquartered in Saint Paul, United States. It is registered at Saint Paul, Minnesota, United States.
Tapemark is a full-service CDMO (contract development and manufacturing organization) providing manufacturing services for drug, device, and combination products. Their capabilities include formulation, blending, coating, converting, packaging, and laboratory services. Drug delivery formats include transdermal drug delivery (claims to be a market leader here), and single-use drug delivery formats such as oral and transmucosal soluble film, topical patches and pads, and Tapemarks patented Snap! and Snapplicator unit-dose packaging for semi-solids. Its labs support Schedule II V Controlled Substances and provide an array of testing services including method development validation, raw material testing, finished product testing and stability services. They also offer microbial limits testing, antimicrobial effectiveness testing, water testing, and environmental monitoring services. Tapemark is cGMP-compliant, and registered with the FDA as a Drug, Device, Food, Cosmetics, and Dietary Supplements contract manufacturer.
Tapemark's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Tapemark has 1 investor. Key investors include LTS Lohmann.